Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling

Diabetes
J GromadaP Rorsman

Abstract

The effect of glucagon-like peptide 1(7-36) amide [GLP-1(7-36) amide] on membrane potential, whole-cell ATP-sensitive potassium channel (K[ATP]) and Ca2+ currents, cytoplasmic Ca2+ concentration, and exocytosis was explored in single human beta-cells. GLP-1(7-36) amide induced membrane depolarization that was associated with inhibition of whole-cell K(ATP) current. In addition, GLP-1(7-36) amide (and forskolin) produced greater than fourfold potentiation of Ca2+-dependent exocytosis. The latter effect resulted in part (40%) from acceleration of Ca2+ influx through voltage-dependent (L-type) Ca2+ channels. More importantly, GLP-1(7-36) amide (via generation of cyclic AMP and activation of protein kinase A) potentiated exocytosis at a site distal to a rise in the cytoplasmic Ca2+ concentration. Photorelease of caged cAMP produced a two- to threefold potentiation of exocytosis when the cytoplasmic Ca2+ concentrations were clamped at > or =170 nmol/l. The effect of GLP-1(7-36) amide was antagonized by the islet hormone somatostatin. Similar effects on membrane potential, ion conductances, and exocytosis were observed with glucose-dependent insulinotropic polypeptide (GIP), the second major incretin. The present data suggest that th...Continue Reading

Citations

Nov 19, 2009·Pflügers Archiv : European journal of physiology·Maria S Remedi, Joseph C Koster
Jul 10, 2003·Molecular and Cellular Endocrinology·Yingrao Tian, Suzanne G Laychock
Jan 19, 2005·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·G G Holz, G Holz
Jun 19, 2013·Critical Reviews in Food Science and Nutrition·O YerlikayaO Kinik
Apr 26, 2008·Diabetes, Obesity & Metabolism·Kasper AaboeJens Juul Holst
Dec 1, 2004·Basic & Clinical Pharmacology & Toxicology·Jesper GromadaPatrik Rorsman
Mar 28, 2012·Journal of Diabetes Investigation·Christopher Hs McIntoshSu-Jin Kim
Aug 28, 2009·The Journal of Pharmacology and Experimental Therapeutics·Sarah Melissa P JacoboGregory H Hockerman
Jan 4, 2007·The Journal of Clinical Investigation·Daniel J Drucker
Nov 21, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Lakshminarayan R Ranganath
Apr 23, 1999·Journal of Basic and Clinical Physiology and Pharmacology·M E Patti, C R Kahn
Nov 10, 2000·Biochemical and Biophysical Research Communications·C A LeechJ F Habener
Sep 15, 2012·Annual Review of Physiology·Patrik Rorsman, Matthias Braun
Jul 24, 2014·Cellular and Molecular Life Sciences : CMLS·Shao-Nian YangPer-Olof Berggren
Aug 15, 2012·The Journal of Physiology·M A BurmeisterJ E Ayala
Aug 16, 2011·Progress in Biophysics and Molecular Biology·Morten Gram PedersenLena Eliasson
Jun 28, 2014·Science China. Life Sciences·Jue Wang, RuiPing Xiao
May 15, 2007·Gastroenterology·Laurie L Baggio, Daniel J Drucker
Feb 20, 2007·Pharmacology & Therapeutics·Máire E Doyle, Josephine M Egan
Mar 10, 2009·Journal of Cellular and Molecular Medicine·Tomie MuraokaToshihiko Ishida
Jan 8, 2009·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·T EdholmP M Hellström
Sep 18, 2013·Diabetes, Obesity & Metabolism·D RondasC Mathieu
Nov 10, 2004·Best Practice & Research. Clinical Endocrinology & Metabolism·Laurie L Baggio, Daniel J Drucker
Jun 7, 2011·Expert Opinion on Pharmacotherapy·Thomas ForstAndreas Pfützner
Mar 5, 2015·The Journal of Nutritional Biochemistry·Bruno Rodrigo da Silva LippoFabiano Ferreira
Mar 7, 2006·Cell Metabolism·Daniel J Drucker
Jun 18, 2016·The FEBS Journal·Ji Liu, Zhiping P Pang
Jan 18, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Makoto ShigetoKohei Kaku
Apr 10, 2016·Angewandte Chemie·Johannes BroichhagenDavid J Hodson
Mar 11, 2005·Diabetes/metabolism Research and Reviews·Juris J Meier, Michael A Nauck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.